PRESS RELEASES
Celleration® Completes $30 Million Financing - Proceeds to Fund Expansion of Celleration's Commercialization Efforts. August 7, 2008.
Celleration® announces the publication of a new educational grant-funded series “MIST Therapy® System – Thoughts on Therapy.” March 13, 2007.
Celleration, Inc. announces the publication of a clinical study: Effectiveness of MIST Therapy for the Healing of Chronic Wounds. Dr. Ennis. October 23, 2006.
Celleration, Inc. receives 2005 Tekne Award for Emerging Biotechnology Company. November 17, 2005.
Celleration, Inc. receives $20.6 Million in Series C Funding. November 1, 2005.
Celleration, Inc. announces the Publication of a clinical study: Efficacy of MIST Therapy for the Treatment of Diabetic Foot Ulcers. Dr. Ennis. August, 29 2005.
Celleration, Inc. receives FDA Clearance for Expanded Indication of “Promotes Wound Healing” for the MIST Therapy System. May 24, 2005.
Celleration, Inc. receives Best Application Award at the Ultrasonic Industry Association's Annual Meeting for the MIST Therapy System. April 12, 2005.
Celleration, Inc. receives FDA Clearance for MIST Therapy System. June 25, 2004.
| 
